Caracteristicas cognitivas y oculares en enfermedad de Alzheimer
Compartir
Autor
Garzón P, Sandra Johanna
Camacho M, Marcela
Tapiero L., Jessica Andrea
Reina, Karen Daniela
Publicador
Universidad Colegio Mayor de CundinamarcaCitación
Gestores bibliográficos
Metadatos
Mostrar el registro completo del ítemResumen
La enfermedad de Alzheimer/AD es un trastorno neurodegenerativo progresivo que afecta la memoria y todas las funciones cognitivas con una edad de inicio tardío o precoz, y se presenta con una muy baja frecuencia por causa genética por alteración en el gen de la PPA, PS1 O PS2. El elemento etiológico mayor conocido es genético, con múltiples factores de susceptibilidad en interacción con factores medioambientales. Las guías de diagnóstico para la AD incluyen evaluaciones psicológicas, psiquiátricas y neurológicas con función cerebral, y no incluyen estudios de la función visual como parte del protocolo diagnóstico, siendo fuerte la evidencia de cambios oculares en retina y en algunas funciones visuales que aparecen aun sin el deterioro cognitivo característico de esta enfermedad. Objetivo. Describir las características cognitivas y oculares en la enfermedad de Alzheimer. Metodología. Se realizó una revisión documental de literatura científica en las bases de datos PubMed, Science Direct, Hinari y Ebsco Ebsco, Proquest, entre otras, con un periodo de búsqueda de los últimos 10 años, mediante los términos mesh “Alzheimer Disease and ocular changes”, “visual cognitive alteration in Alzheimer” “retina and Alzheimerdisease”. Resultados: La AD presenta un proceso neurodegenerativo con deterioro cognitivo, que se presenta en todas las regiones de la corteza cerebral, iniciándose en corteza del hipocampo y amígdala cerebral desde donde progresa a la circunvolución para-hipocampal, lóbulos temporales y frontales. Conclusiones. Varios estudios han demostrado que la AD presenta alteraciones en memoria, lenguaje, orientación visoespacial, acompañada por cambios estructurales en cerebro y en la retina al reducir el espesor de las células ganglionares, de las capas de fibras nerviosas ...
Escuela
http://hemeroteca.unad.edu.co/index.php/nova/article/view/2693/2797/*ref*/Patrick E, Rajagopal S, Wong H-KA, McCabe C, Xu J, Tang A, et al. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease. Mol Neurodegener [Internet]. 2017;12(1):51. Available from: http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0191-y
/*ref*/Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol [Internet]. 2014;71(11):1394–404. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25199842%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4314944
/*ref*/Reitz C, Mayeux R. Alzheimer disease: Epidemiology, Diagnostic Criteria, Rist Factors and Biomarkers. Biochem Pharmacol. 2014;88(4):640–51.
/*ref*/Javaid FZ, Brenton J, Guo L, Cordeiro MF. Visual and ocular manifestations of Alzheimer’s disease and their use as biomarkers for diagnosis and progression. Front Neurol. 2016;7(APR).
/*ref*/Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M. Ocular indicators of Alzheimer’s: exploring disease in the retina. Acta Neuropathol [Internet]. 2016;132(6):767–87. Available from: https://doi.org/10.1007/s00401-016-1613-6
/*ref*/Lang A, Carass A, Al-Louzi O, Bhargava P, Solomon SD, Calabresi PA, et al. Combined registration and motion correction of longitudinal retinal OCT data. 2016;97840X. Available from: http://proceedings.spiedigitallibrary.org/proceeding.aspx?doi=10.1117/12.2217157
/*ref*/Haaksma ML, Vilela LR, Marengoni A, Caldero A, Leoutsakos JS, Rikkert MGMO. Comorbidity and progression of late onset Alzheimer ’ s disease : A systematic review. 2017;(May):1–15.
/*ref*/Lopera F. La enfermedad de Alzheimer familiar. Desde la Bibl [Internet]. 2016;0(51):63–73. Available from: http://itmojs. itm.edu.co/index.php/desdelabiblioteca/article/view/915
/*ref*/Chao, MD, MSc*, J. Scott Roberts, PhD†, Theresa M. Marteau, PhD‡, Rebecca Silliman, MD, PhD*,§, L. Adrienne Cupples, PhD‡, and Robert C. Green, MD M. Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study. Alzheimer Dis Assoc Disord. 2008;100(2):130–4.
/*ref*/Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol [Internet]. 2003;60(4):510–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12707064
/*ref*/Leoni V. Oxysterols as markers of neurological disease - A review. Scand J Clin Lab Invest. 2009;69(1):22–5.
/*ref*/Pawlowski M, Meuth SG, Duning T. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside. Diagnostics [Internet]. 2017;7(3):42. Available from: http://www.mdpi.com/2075-4418/7/3/42
/*ref*/Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615–9.
/*ref*/Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer’s disease. Int J Exp Pathol [Internet]. 2005;86(3):139–45. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=2517412&-tool=pmcentrez&rendertype=abstract
/*ref*/Herrera-Rivero M, Hernández-Aguilar ME, Manzo J, Aranda- Abreu GE. Alzheimer â€TM s disease : Immunity and diagnosis Enfermedad de Alzheimer : inmunidad y diagnóstico. Rev Neurol. 2016;(November).
/*ref*/Chiasseu M, Alarcon-Martinez L, Belforte N, Quintero H, Dotigny F, Destroismaisons L, et al. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease. Mol Neurodegener [Internet]. 2017;12(1):58. Available from: http://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-017-0199-3
/*ref*/Custodio N, Montesinos R, Alva C, Mejía K, Becerra Y, Lira D. Nuevos términos clínicos , prevención y tratamiento del trastorno cognitivo vascular : revisión de literatura basada en la evidencia. Rev Neuropsiquiatr [Internet]. 2016;79(3):152–65. Available from: http://www.scielo.org.pe/pdf/rnp/v79n3/a04v79n3.pdf
/*ref*/Minsalud. Informe al Congreso de la República 2014-2015. Minist Salud y Protección Soc [Internet]. 2015;194. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PES/informe-congreso-2014-2015.pdf
/*ref*/Armstrong R a. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol. 2009;47(4):289–99.
/*ref*/Sánchez CR De, Nariño D, Fernando J, Cerón M. Epidemiología y carga de la Enfermedad de Alzheimer. Acta Neurológica Colomb. 2010;26(3):87–94.
/*ref*/Hurtado AMA, Quintana ASSR. Relación entre la calidad de vida en salud y la carga física en uidadores de personas con enfermedad de Alzheimer. Rev Colomb Salud Ocup. 2016;6(1):18–23.
/*ref*/Carvajal-castrillón J, Marina L, Toro G, Estrada DO, Ramírez AA, Peláez AR, et al. Prevalencia de síndromes neuropsicológicos del adulto en una unidad de neuropsicología en Medellín , Colombia Prevalence of adult neuropsychological syndromes in a neuropsychology unit. Acta Neurológica Colomb.2015;31(1):20–6.
/*ref*/Batsch NL, Mittelman MS. Overcoming the stigma of dementia, World Alzheimer Report 2012 [Internet]. Www.Alz. Co.Uk. 2012. 1-80 p. Available from: papers2://publication/uuid/889ADA69-3B6E-4DCC-BF40-936650E90072
/*ref*/Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N Engl J Med [Internet]. 2012;367(9):795–804. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1202753
/*ref*/Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL. Alzheimer’s disease prevention: from risk factors to early intervention.Alzheimers Res Ther [Internet]. 2017;9(1):71. Available from: http://alzres.biomedcentral.com/articles/10.1186/s13195-017-0297-z
/*ref*/Ji F, Pasternak O, Liu S, Loke YM, Choo BL, Hilal S, et al. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer’s disease with and without cerebrovascular disease. Alzheimers Res Ther [Internet]. 2017;9(1):63. Available from: http://alzres.biomedcentral.com/articles/10.1186/s13195-017-0292-4
/*ref*/Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. Exp Gerontol [Internet]. 2017; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0531556517302280
/*ref*/Epperly T, Dunay MA, Boice JL. Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms. Am Fam Physician. 2017;95(12):771–8.
/*ref*/Tam WK, Chan H, Brown B, Leung KW, Woo V, Yap M. Aging and mfERG topography. Eye. 2006;20(1):18–24.
/*ref*/Hollands C, Tobin MK, Hsu M, Musaraca K, Yu T-S, Mishra R, et al. Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer’s disease by compromising hippocampal inhibition. Mol Neurodegener [Internet]. 2017;12(1):64. Available from: http://molecularneurodegeneration. biomedcentral.com/articles/10.1186/s13024-017-0207-7
/*ref*/Chan D, Gallaher LM, Moodley K, Minati L, Burgess N, Hartley T. The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer’s Disease. J Vis Exp [Internet]. 2016;(116). Available from: http://www.jove.com/video/54454/the-4-mountains-test-short-test-spatial-memory-with-high-sensitivity
/*ref*/Bruni BM, Granado FB, Prado RA. Avaliação do equilíbrio postural em idosos praticantes de hidroterapia em grupo. O Mundo da Saúde. 2008;32(1):56–63.
/*ref*/Mar J, Soto-Gordoa M, Arrospide A, Moreno-Izco F, Martínez-Lage P. Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia.Alzheimers Res Ther [Internet]. 2015;7(1):2. Available from: http://alzres.com/content/7/1/2
/*ref*/EC M, KV P. Cognitive decline in preclinical stage 2 alzheimer disease and implications for prevention trials. JAMA Neurol [Internet]. 2016 Jun 1;73(6):640–2. Available from: http://dx.doi.org/10.1001/jamaneurol.2016.0281
/*ref*/TRABAJO FIN DE GRADO TÍTULO : “ BIOMARCADORES EN LA ENFERMEDAD DE ALZHEIMER .”2016 :1–22.
/*ref*/Ma D, Alonso E, Ana D, Sosa L, Sotelo J, Ausman J, et al. Visión actual de las demencias. Arch Neurociencias.2016;21(Suplemento Especial):1–8.
/*ref*/Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer’s Dement Diagnosis, Assess Dis Monit [Internet]. 2017;6:108–21. Available from: http://dx.doi. org/10.1016/j.dadm.2016.09.002
/*ref*/TL K, Goldacre R, MJ G. Associations between age-related macular degeneration, alzheimer disease, and dementia: Record linkage study of hospital admissions. JAMA Ophthalmol [Internet]. 2014 Jan 1;132(1):63–8. Available from: http://dx.doi.org/10.1001/jamaophthalmol.2013.5696
/*ref*/Williams MA, McGowan AJ, Cardwell CR, Cheung CY, Craig D, Passmore P, et al. Retinal microvascular network attenuation in Alzheimer’s disease. Alzheimer’s Dement Diagnosis, Assess Dis Monit [Internet]. 2015;1(2):229–35. Available from: http://dx.doi.org/10.1016/j.dadm.2015.04.001
/*ref*/Schwitzer T, Schwan R, Bubl E, Lalanne L, Angioi-Duprez K, Laprevote V. Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidences. Prog Neuro-Psychopharmacology Biol Psychiatry [Internet]. 2017;76(January):155–62. Available from: http://dx.doi.org/10.1016/j.pnpbp.2017.03.008
/*ref*/den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis. Alzheimer’s Dement Diagnosis, Assess Dis Monit[Internet]. 2017;6:162–70. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2352872916300793
/*ref*/Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, et al. Retinal Nerve Fiber Layer Thinning in Alzheimer’s Disease. Am J Alzheimer’s Dis Other Dementiasr [Internet]. 2016;31(5):430–6. Available from: http://journals.sagepub.com/doi/10.1177/1533317515628053
/*ref*/Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, et al. Optical coherence tomography in Alzhei mer’s disease: A meta-analysis. PLoS One. 2015;10(8):1–14.
/*ref*/Ong YT, Hilal S, Cheung CY, Venketasubramanian N, Niessen WJ, Vrooman H, et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett. 2015;584:12–6.
/*ref*/Khawaja AP, Chan MPY, Yip JLY, Broadway DC, Garway-Heath DF, Luben R, et al. Retinal Nerve Fiber Layer Measures and Cognitive Function in the EPIC-Norfolk Cohort Study. Investig Opthalmology Vis Sci [Internet]. 2016;57(4):1921.Available from: http://iovs.arvojournals.org/article.aspx?-doi=10.1167/iovs.16-19067
/*ref*/La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016;79(1):90–109.
/*ref*/Pavisic IM, Firth NC, Parsons S, Rego DM, Shakespeare TJ, Yong KXX, et al. Eyetracking metrics in young onset alzheimer’s disease: A Window into cognitive visual functions. Front Neurol. 2017;8(AUG):1–16.
/*ref*/Kirby E, Bandelow S, Hogervorst E. Visual Impairment in Alzheimer’s Disease: A Critical Review. Vol. 21, Journal of Alzheimer’s disease : JAD. 2010. 15-34 p.
/*ref*/Pal S, Sanyal D, Biswas A, Paul N, Das SK. Visual Manifestations in Alzheimer’s disease: A Clinic-Based Study From India. Am J Alzheimer’s Dis Other Dementiasr [Internet]. 2013 Jul 2;28(6):575–82. Available from: https://doi.org/10.1177/1533317513494448
/*ref*/García EP, Echevarría IOH, Rodríguez IY. Obtención , interpretación y usos del electrorretinograma multifocal Obtaining , interpreting and using the multifocal electroretinogram.2016;29(1):105–23.
/*ref*/Bernal Luz Mery, López Greizy. Diagnóstico prénatal: retrospectiva. Nova. 2014; 12( 21 ): 23-36.
/*ref*/Márquez Gómez Marco Antonio, Gómez Díaz Graciela María. Accidente ofídico en el departamento de Sucre, Colombia.Nova. 2015; 13( 24 ): 39-46.
/*ref*/González Yuri Lilian. Evaluación de la percepción del riesgo ocupacional en trabajadores de una empresa del sector de la construcción en Bogotá D.C. Nova. 2015; 13( 23 ): 93-107.
/*ref*/Naranjo Flórez Ricardo Andrés. Avances y perspectivas en Síndrome de Asperger. Nova. 2014; 12( 21 ): 81-101.
/*ref*/Almonacid Urrego Carmen Cecilia, Camarillo Romero María del Socorro, Gil Murcia Zulay, Medina Medina Claudia Yasmin, Rebellón Marulanda Jennifer Viviana, Mendieta Zerón Hugo. Evaluación de factores de riesgo asociados a enfermedad cardiovascular en jóvenes universitarios de la Localidad Santafé en Bogotá, Colombia. Nova. 2016; 14(25): 9-17.
/*ref*/González Devia Johanna L., Monroy Romero Paola A., Almonacid Urrego Carmen C.. Homocisteína y otros factores de riesgo cardiovascular en niños de educación básica primaria del Colegio Distrital Manuel Elkin Patarroyo, Bogotá, D.C. Colombia. Estudio piloto. Nova. 2017 ; 15( 27 ): 103-117.
/*ref*/Armstrong RA, Syed AB. Alzheimer’s disease and the eye. Ophthalmic Physiol Opt [Internet]. 2009;16(SUPPL. 1):103–11. Available from: http://dx.doi.org/10.3921/joptom. 2009.103
/*ref*/Sivak, J. The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer’s Brain and Retinal Disease. Investigative Ophthalmology & Visual Science. [Internet] 2013, Vol. 54, No. 1. Available from: doi:10.1167/iovs.12-10827
Formato
application/pdfTipo de Recurso Digital
info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion
reviewArticle
reviewArticle
reviewArticle
Colecciones
- Revista Nova [1114]